During the past decade, Instituto Nacional de Cancer Jose Alencar Gomes da Silva - INCA conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Instituto Nacional de Cancer Jose Alencar Gomes da Silva - INCA" #1 collaborator was "Eli Lilly and Company" with 1 trials as a collaborator, "Libbs Farmacêutica LTDA" with 1 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator and "Ono Pharmaceutical Co. Ltd" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Instituto Nacional de Cancer Jose Alencar Gomes da Silva - INCA" are "Advanced Cholangiocarcinoma" (1 trials), "FGFR2 Gene Rearrangements" (1 trials), "Graft Vs Host Disease" (1 trials), "Hematopoietic Neoplasm" (1 trials) and "Neoplasms" (1 trials). Many other conditions were trialed in "Instituto Nacional de Cancer Jose Alencar Gomes da Silva - INCA" in a lesser frequency.

Most popular intervention types in "Instituto Nacional de Cancer Jose Alencar Gomes da Silva - INCA" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "5-FU" (1 trials), "Bevacizumab" (1 trials), "Capecitabine" (1 trials), "Cetuximab" (1 trials) and "Cisplatin/Gemcitabine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Instituto Nacional de Cancer Jose Alencar Gomes da Silva - INCA" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Instituto Nacional de Cancer Jose Alencar Gomes da Silva - INCA". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Instituto Nacional de Cancer Jose Alencar Gomes da Silva - INCA, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Instituto Nacional de Cancer Jose Alencar Gomes da Silva - INCA, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".